EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria

Marian Klose, Lea Weber, Hagen Sjard Bachmann iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0331440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Marian Klose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research (ZBAF), School of Medicine, Witten/Herdecke…. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Farnesyltranstransferase, Gram-Negative Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of antibiotic resistance continues to pose a significant global challenge. Drug repurposing, wherein existing therapeutics are evaluated for new applications, offers a promising strategy to address this issue. Farnesyltransferase inhibitors (FTIs), initially developed for cancer therapy, have demonstrated antimicrobial activity against several gram-positive bacteria. This study investigates their activity in combination with colistin against gram-positive and gram-negative bacteria. We focus on key ESKAPE ( E nterococcus faecium , S taphylococcus aureus , K lebsiella pneumoniae , A cinetobacter baumannii , P seudomonas aeruginosa , and E nterobacter species) pathogens while incorporating additional bacterial strains to provide a comprehensive understanding of differential responses and potential dose-dependent synergistic effects. Antimicrobial susceptibility was assessed using broth microdilution, while synergy was evaluated through checkerboard, time-kill, and growth kinetics assays. When combined with sub-inhibitory colistin, FTIs inhibited gram-negative bacterial growth. Tipifarnib exhibited more potent antimicrobial activity against gram-negative strains than lonafarnib. Peptidomimetic FTIs, B581 and FTI-277, inhibited gram-negative bacteria in combination with colistin but had no effect on the gram-positive strains tested. In contrast, alpha-hydroxy farnesyl phosphonic acid, an FPP analog, and bempedoic acid, targeting the mevalonate pathway, showed no antibacterial activity. In addition to their known inhibition of gram-positive bacteria, FTIs exhibited efficacy against gram-negative bacteria, including colistin-resistant Enterobacter cloacae subsp. cloacae , when combined with sub-inhibitory colistin. This might be due to a mechanism distinct from their eukaryotic targets, potentially involving the disruption of multiple biosynthetic pathways. Future studies will focus on elucidating these mechanisms of FTIs and exploring the therapeutic potential of FTI/colistin combinations against ESKAPE and other multidrug-resistant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinAnti-Bacterial AgentsFarnesyltranstransferaseGram-Negative BacteriaEnzyme InhibitorsGram-Positive BacteriaDrug SynergismMicrobial Sensitivity TestsQuinolonesPyridinesDibenzocycloheptenesPiperidines

Substanzen

ColistinAnti-Bacterial AgentsFarnesyltranstransferaseEnzyme InhibitorsQuinoloneslonafarnibtipifarnibPyridinesDibenzocycloheptenesPiperidines

Autor:innen und Institutionen

  • Faculty of Health, Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research (ZBAF), School of Medicine, Witten/Herdecke University, Witten, Germany.

ORCID-Profile: Hagen Sjard Bachmann

Zitieren

APA

Klose, M., Weber, L., & Bachmann, H. S. (2025). In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. PLOS One. https://doi.org/10.1371/journal.pone.0331440

Vancouver

Klose M, Weber L, Bachmann HS. In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. PLOS One. 2025. doi:10.1371/journal.pone.0331440

BibTeX
@article{Klose2025,
  author = {Klose, Marian and Weber, Lea and Bachmann, Hagen Sjard},
  title = {In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331440}
}
Kostenlos starten →